6-Methylene-13-phenyl-4,8-di(p-toluenesulfonyl)-4,8,15-triazabicyclo[9.3.1]pentadeca-1(15),11,13-triene Hydrochloride

ID: ALA4748787

Chembl Id: CHEMBL4748787

PubChem CID: 162649585

Max Phase: Preclinical

Molecular Formula: C33H36ClN3O4S2

Molecular Weight: 601.79

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(-c3ccccc3)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl

Standard InChI:  InChI=1S/C33H35N3O4S2.ClH/c1-25-9-13-32(14-10-25)41(37,38)35-19-17-30-21-29(28-7-5-4-6-8-28)22-31(34-30)18-20-36(24-27(3)23-35)42(39,40)33-15-11-26(2)12-16-33;/h4-16,21-22H,3,17-20,23-24H2,1-2H3;1H

Standard InChI Key:  JDQVGEOUKHGYPV-UHFFFAOYSA-N

Associated Targets(Human)

CD4 Tclin T-cell surface antigen CD4 (114 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 601.79Molecular Weight (Monoisotopic): 601.2069AlogP: 5.40#Rotatable Bonds: 5
Polar Surface Area: 87.65Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 3.96CX LogP: 5.83CX LogD: 5.83
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.29Np Likeness Score: -0.53

References

1. Lumangtad LA,Claeys E,Hamal S,Intasiri A,Basrai C,Yen-Pon E,Beenfeldt D,Vermeire K,Bell TW.  (2020)  Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.,  28  (24): [PMID:33181479] [10.1016/j.bmc.2020.115816]
2. Berger K, Pauwels E, Parkinson G, Landberg G, Le T, Demillo VG, Lumangtad LA, Jones DE, Islam MA, Olsen R, Kapri T, Intasiri A, Vermeire K, Rhost S, Bell TW..  (2021)  Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds.,  64  (17.0): [PMID:34428050] [10.1021/acs.jmedchem.1c00943]

Source